Budget Continues AHRQ's Role As Leader On Comparative Effectiveness Work
The Agency for Healthcare Research and Quality's budget request for comparative effectiveness research gives the impression that, in the wake of the stalled health care reform legislation, the Obama administration is bolstering AHRQ's claim to be the lead organization for CER
More from Archive
More from Pink Sheet
Clarity on what transferable exclusivity vouchers may look like for new antimicrobial drugs could be nearing. Denmark’s new presidency of the Council of the EU has prioritized concluding its negotiations with European Parliament over the legislative overhaul of the EU’s pharmaceutical legislation.
After pursuing Alchem International for breaches of EU antitrust rules – relating to a cartel over the SNBB pharmaceutical ingredient used in Buscopan and its generics – the European Commission has now hit the firm with a €489,000 fine.
Bayesian statistics could help clinical trial sponsors to include external information in their analyses, but concerns around bias and incorrect conclusions remain, the European Medicines Agency said.